US 6489299
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
expired A61KA61K38/00A61P
Quick answer
US patent 6489299 (Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein) held by Neurocrine Biosciences, Inc. expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61P, A61P25/00, A61P25/28